Loading…
avatar for Mark Kieran

Mark Kieran

Bristol-Myers Squibb
Clinical Trail Lead, Pediatrics Program Oncology Clinical Development
Dr. Kieran is currently the Pediatric Clinical Trial Lead in Oncology Clinical Development, Bristol-Myers Squibb. He received his PhD in 1983 from the University of Alberta, Edmonton, Canada, and his MD in 1986 from the University of Calgary. After a post-doctoral fellowship at the Pasteur Institute in Paris, France, he completed a pediatric residency at McGill University in Montreal and a pediatric oncology fellowship at Boston Children’s Hospital. Dr. Kieran was named Director of Pediatric Neuro-Oncology at the Dana-Farber Cancer Institute in 1999 until his move to BMS in 2018. His interests include the genomic identification of mutations and incorporation of targeted, biologic, immune and gene therapy for children with brain tumors.

My Speakers Sessions

Wednesday, June 26
 

10:30am